Mesalazine (PENTASA) in Ulcerative Colitis: Correlation of the Information Level With Patient's Compliance in Everyday Practice.
Phase of Trial: Phase IV
Latest Information Update: 06 Jun 2014
At a glance
- Drugs Mesalazine (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Acronyms MUKOSA
- Sponsors Ferring Pharmaceuticals
- 07 Jun 2017 Biomarkers information updated
- 14 Apr 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Apr 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.